Sebi on Wednesday barred six entities from the capital markets for two years for indulging in manipulative trading in the shares of Bioco...Read More
By FPJ Web Desk
Bangalore-based Biocon reported a 26 per cent rise in consolidated revenue from Rs 1,621 crore in Q4FY20 to Rs 2,044 crore in Q4FY 2021. ...Read More
Kiran Mazumdar Shaw, Executive Chairperson, Biocon Ltd has been appointed to the board of trustees of US-based Memorial Sloan Kettering C...Read More
Global biopharmaceutical company Biocon has launched its generic drugs in the Brazil market. The company is making an entry into Latin A...Read More
Mazumdar-Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"
The company's revenue from operations rose to Rs 1,851 crore for the quarter under consideration, up 7.81 per cent, as against Rs 1,716.8...Read More
A total of 31 women in the list of 100 having a networth of at least Rs 100 crore, prepared by Hurun India and Kotak Wealth, are "self-ma...Read More
The indicative time period for completion of the acquisition is December 15, 2020, Biocon said in a BSE filing.
Chairperson and managing director of Bengaluru-based Biocon Kiran Mazumdar Shaw said a vaccine for COVID-19 could be available in India b...Read More
Bengaluru: Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested COVID-19 positive."I have added to the COVID count by t...Read More
New Delhi: Shares of biotechnology major Biocon on Friday dropped nearly 4 per cent after the company reported a 26.30 per cent decline i...Read More
Biocon’s subsidiary Biocon Biologics has received Drugs Controller General of India’s (DCGI) approval to use CytoSorb to treat critical C...Read More
The company had posted a net profit of Rs 214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.
Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia.
The company had posted a net profit of Rs 217.2 crore for the corresponding period of the previous fiscal, Biocon said.
New Delhi: Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.4...Read More
By Rupesh Shetty
Mazumdar Shaw, who is also a chairman of Biocon, was alleged to have violated provisions of the Prohibition of Insider Trading (PIT) regu...Read More
New Delhi: Biotechnology major Biocon reported a net profit of Rs 215.7 crore for the quarter ended September 30, 2019.The company had p...Read More
On Thursday Finance Minister Nirmala Sitharaman had defended her decision to ban e-cigarettes after Biocon chief Kiran Mazumdar-Shaw ques...Read More
Reminds Biocon chief of govt's fiscal steps on growth revival